Reyvow was approved by the FDA last October and became available for prescription Jan. 31.
Patients will not necessarily pay $640 for eight pills, depending on the duration of treatment and their healthcare plan.
Eli Lilly also said it will offer a Reyvow savings card to eligible patients to help them lower their out-of-pocket costs.
Read the full article here.
More articles on pharmacy:
Walgreens pays $7.5M to resolve claims an employee impersonated a pharmacist
SwedishAmerican opens ScriptCenter, a self-serve pharmacy kiosk
Walgreens CEO talks strategy, skips buyout speculation at annual meeting
